Ron Kleiner

Tel Aviv, TA 69978, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Harnessing the power of microbiome, nanotechnology, and immunity against cancer.

Harnessing the power of microbiome, nanotechnology, and immunity against cancer.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: October 22, 2025

Patient-Derived 3D-Bioprinted Models of Pancreatic Cancer: Toward Personalized Therapy and Overcoming Tumor Microenvironment Challenges.

Patient-Derived 3D-Bioprinted Models of Pancreatic Cancer: Toward Personalized Therapy and Overcoming Tumor Microenvironment Challenges.

Journal: Advanced drug delivery reviews

Published: April 20, 2025

Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin-expressing cancers.

Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin-expressing cancers.

Journal: Science advances

Published: December 13, 2024

Intranasal Multiepitope PD-L1-siRNA-Based Nanovaccine: The Next-Gen COVID-19 Immunotherapy.

Intranasal Multiepitope PD-L1-siRNA-Based Nanovaccine: The Next-Gen COVID-19 Immunotherapy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 21, 2024

Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy.

Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy.

Journal: Advanced functional materials

Published: January 29, 2024

Meet me halfway: Are in vitro 3D cancer models on the way to replace in vivo models for nanomedicine development?

Meet me halfway: Are in vitro 3D cancer models on the way to replace in vivo models for nanomedicine development?

Journal: Advanced drug delivery reviews

Published: February 07, 2021

Preclinical models and technologies to advance nanovaccine development.

Preclinical models and technologies to advance nanovaccine development.

Journal: Advanced drug delivery reviews

Published: January 26, 2021

P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression.

P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression.

Journal: Nature communications

Published: August 11, 2020

Immune-mediated approaches against COVID-19.

Immune-mediated approaches against COVID-19.

Journal: Nature nanotechnology

Published: April 11, 2020

Tailoring the lipid composition of nanoparticles modulates their cellular uptake and affects the viability of triple negative breast cancer cells.

Tailoring the lipid composition of nanoparticles modulates their cellular uptake and affects the viability of triple negative breast cancer cells.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: February 27, 2019

Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators.

Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators.

Journal: Nature nanotechnology

Published: April 24, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026